Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG Vaccination at First Health-facility Contact to Reduce Early Infant Mortality
NCT04658680Phase 4Active, not recruiting
- Sponsor
- Bandim Health Project
- Start
- Feb 2021
- Primary completion
- Mar 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of bcg vaccine in Infant mortality (IMR), sponsored by Bandim Health Project. Started Feb 2021; status: active, not recruiting.
02
Drugs
bcg vaccine
03
Conditions
Infant mortality (IMR)
Beyond the preview
Go deeper on NCT04658680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04658680.